Response Surface Methodology Optimization of Thebaine Biotransformation into Codeine and Morphine Using Bacillus sp. FAR
Nazanin Ataee1, Jamshid Fooladi2★, Mohammad Hasan Namaei3, Fateme Mirzajani4★ Corresponding author
- 1Department of Microbiology, Faculty of Biological Science, Alzahra University, Vanak, Tehran, IRAN.
- 2Department of Biotechnology, Faculty of Biological Science, Alzahra University, Vanak, Tehran, IRAN.
- 3Birjand Infectious Diseases Research Center, Birjand University of Medical Sciences, Ghafary Ave., Birjand, IRAN.
- 4Departmrnt of Nanobiotechnology, Protein Research Center (PRC), Shahid Beheshti University, G.C., Tehran, IRAN.
CORRESPONDENCE
Jamshid Fooladi
Department of Biotechnology, Faculty of Biological Science, Alzahra University, Vanak, Tehran, IRAN.
Received: 29-01-2017; Revised: 15-03-2017; Accepted: 30-03-2017.
Volume 51, Issue 4 · pp. 684–691 · PUBLISHED 2017 · DOI: 10.5530/ijper.51.4.101
ABSTRACT
Background: Codeine and morphine are important pharmaceuticals having analgesic characteristics. Aim: The current study used response surface methodology to optimize the biotransformation of thebaine into codeine and morphine using Bacillus sp. FAR. Methods: A central composite design was used to determine the optimal concentrations of buffer and thebaine, pH, time, temperature, and biomass. Improvement in transformation was monitored using HPLC-DAD. Results: The optimized conditions employed were pH 7.7 at 36°C for 30 h using a thebaine concentration of 80 μg/mL, 45 mM tris of buffer and 2.9% w/v biomass. The optimal conditions for codeine and morphine production were 2.995 and 1.113 μg, respectively. Conclusion: Optimization demonstrated that pH and biomass had the strongest effects on biotransformation.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Ataee, N., Fooladi, J., Namaei, M. H., & Mirzajani, F. (2017). Response Surface Methodology Optimization of Thebaine Biotransformation into Codeine and Morphine Using Bacillus sp. FAR. Indian Journal of Pharmaceutical Education and Research, 51(4), 684–691. https://doi.org/10.5530/ijper.51.4.101
